Market Tracker

01/22 3:03pm ET

Repligen Corp (NASDAQ:RGEN)

36.11
Delayed Data
As of 2:48pm ET
 +0.33 / +0.92%
Today’s Change
28.48
Today|||52-Week Range
46.81
-0.47%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close35.78
Today’s open35.98
Day’s range35.52 - 36.40
Volume159,149
Average volume (3 months)403,749
Market cap$1.6B
Data as of 2:48pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+40.06%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio63.4
Price/Sales10.05
Price/Book7.18

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.20+0.99%
ARRYArray Biopharma Inc+2.28+17.35%
LXRXLexicon Pharmaceutic...+0.38+3.64%
CBMCambrex Corp-0.10-0.18%
Data as of 3:03pm ET, 01/22/2018

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts